Detection and identification of platelet-associated alloantibodies by a solid-phase modified antigen capture enzyme-linked immunosorbent assay method and its correlation to platelet refractoriness in multiplatelet concentrate–transfused patients
Vassallo RR. Recognition and management of antibodies to human platelet antigens in platelet transfusion-refractory patients. Immunohematology 2009;25:119–24.10.21307/immunohematology-2019-244Search in Google Scholar
Slichter SJ, Kaufman RM, Assmann SF, et al. Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med 2010;362:600–13.10.1056/NEJMoa0904084295132120164484Search in Google Scholar
Rebulla P. Refractoriness to platelet transfusion. Curr Opin Hematol 2002;9:516−20.10.1097/00062752-200211000-0000912394175Search in Google Scholar
[No authors listed]. The Trial to Reduce Alloimmunization to Platelets Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.. N Engl J Med 1997;337:1861–9.10.1056/NEJM1997122533726019417523Search in Google Scholar
Murphy MF, Metcalfe P, Thomas H, et al. Use of leucocyte-poor blood components and HLA-matched-platelet donors to prevent HLA alloimmunization. Br J Haematol 1986;62: 529–34.10.1111/j.1365-2141.1986.tb02965.x3954967Search in Google Scholar
Laundy GJ, Bradley BA, Rees BM, Younie M, Hows JM. Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia. Transfusion 2004;44: 814–25.10.1111/j.1537-2995.2004.03387.x15157245Search in Google Scholar
Legler TJ, Fischer I, Dittmann J, et al. Frequency and causes of refractoriness in multiply transfused patients. Ann Hematol 1997;74:185–9.10.1007/s0027700502809174547Search in Google Scholar
